Skip to main content

Navigating Alzheimer's Risk: Virtual Reality Reveals Early Cognitive Changes

Written by Andrew Le, MD

UpdatedApril 12, 2024

Midlife adults at risk of Alzheimer's disease may experience cognitive changes long before traditional symptoms arise, suggests a recent study leveraging virtual reality (VR) technology. Researchers assert that deficits in entorhinal cortex function, critical for path integration—or the ability to mentally track distance and direction—could precede the memory impairments commonly associated with Alzheimer's. This groundbreaking study, published in Alzheimer’s & Dementia and accessible via DOI: 10.1002/alz.13733, links entorhinal cortex–based path integration to midlife Alzheimer's disease risk.

The study involved 100 asymptomatic middle-aged adults, whose cognitive abilities were meticulously evaluated using immersive VR to simulate navigation tasks. Data were meticulously correlated with intricate 7T magnetic resonance imaging (MRI) scans to gain insights into brain structure and function. Although participants presented no overt cognitive impairment, significant PI disabilities were uncovered, predicting Alzheimer's risk factors both hereditary and physiological.

In particular, the findings revealed a striking deficit in PI performance when participants were deprived of environmental orientation cues, suggesting a distinct difficulty with angular rather than distance estimation. Intriguingly, males with a family history of dementia or those carrying the APOE ε4 allele showed predominantly impaired PI. This discovery might represent a key transition in Alzheimer's pathology, delineating the evolution from a preclinical condition to observable disease onset.

The research, led by Coco Newton and an illustrious team from esteemed institutions, underscores the importance of early detection in Alzheimer's disease. Funded by organizations like the Alzheimer’s Society and the US Alzheimer’s Association, the study presents PI as a potential early biomarker of Alzheimer's, holding promise for future preventive strategies.

For more detailed information, refer to the full article published in "Alzheimer’s & Dementia," which can be accessed through Wiley Online Library at the provided DOI link. This research is part of the larger PREVENT Dementia Research Programme, aimed at identifying predictors of Alzheimer’s disease to preempt its advancement.

Built with the help of .

References

Newton, C., Pope, M., Rua, C., Henson, R., Ji, Z., Burgess, N., Rodgers, C. T., Stangl, M., Dounavi, M.-E., Castegnaro, A., Koychev, I., Malhotra, P., Wolbers, T., Ritchie, K., Ritchie, C. W., O'Brien, J., Su, L., Chan, D., & for the PREVENT Dementia Research Programme. (2024). Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's disease. Alzheimer's & Dementia, 1-15. https://doi.org/10.1002/alz.13733